✦ LIBER ✦

Adjuvant therapy for breast cancer — results from the USA consensus conference

✍ Scribed by Jeffrey S. Abrams

Publisher: Springer Japan
Year: 2001
Tongue: English
Weight: 781 KB
Volume: 8
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02967528

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The NIH Consensus Development Conference

The NIH Consensus Development Conference on Adjuvant Chemotherapy for Breast Cancer — a commentary

✍ Marc E. Lippman 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 621 KB

Ocular toxicity during adjuvant chemoend

Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer : Results from International Breast Cancer Study Group Trials

✍ Lorenzo Gianni; Ilaria Panzini; Sigui Li; Richard D. Gelber; John Collins; Stig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Radiation therapy in operable breast can

Radiation therapy in operable breast cancer: Results from the Stockholm trial on adjuvant radiotherapy

✍ Arne Wallgren; Ored Arner; Jan Bergström; Bertil Blomstedt; Per-Ola Granberg; La 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 614 KB

The predictive value of angiogenesis for

The predictive value of angiogenesis for adjuvant therapy in Breast Cancer

✍ Masakazu Toi; Hiroko Bando; Katsumasa Kuroi 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 498 KB

The use of aromatase inhibitors in adjuv

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

✍ Walter Jonat; Felix Hilpert; Nicolai Maass 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 250 KB

Persistence of bone marrow micrometastas

Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 years

✍ Martin J. Slade; Anjana Singh; Brendan M. Smith; Gopi Tripuraneni; Emma Hall; Cl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB

We have previously developed a quantitative PCR (QPCR) technique for the detection of cytokeratin 19 (CK19) transcripts in blood and bone marrow and compared this to immunocytochemistry (ICC). Together, both have shown promise for monitoring therapeutic efficacy in patients with metastatic breast ca